Home »Supplements » RENACON PHARMA LIMITED…IPO FOR A VERTICAL GROWTH

  • News Desk
  • Oct 28th, 2017
  • Comments Off on RENACON PHARMA LIMITED…IPO FOR A VERTICAL GROWTH
There are approximately more than 2.6 million patients of 'complete Kidney failure" in the world who are getting Blood Dialysis (Hemodialysis) thrice weekly in order to remain alive. The average increase in number of these patient is about 200 new patients per million population per year hence Pakistan will be having 40,000 & India 200,000 new patients each year apart from previous ones. Unfortunately 80-90% of these die in developing countries due to non-affordability and non-availability of dialysis. Apart from dialysis machines hemodialysis disposables used at each treatment thrice weekly have been the strongest inhibiting factor due to cost. Now as the awareness and technology is expanding the growth rate in the Hemodialysis disposables Industry in developing countries is estimated to be about 25-30% per annum while in developed countries it is 6-8% as everybody gets treatment. Dialysis market value was set at $ 77 billion in 2015 and is set to expand to $ 101.9 billion by 2022.

RENACON PHARMA LIMITED is a research-based company & is the pioneer producer and market leader of all possible types of high-quality powder & solution forms of Dialysis Solutions since 1998 in Pakistan while exclusive producer of certain products changing the quality of life of dialysis patients drastically. Other products are Auto-mixers & disinfectants while several other products developed through R&D successfully aiming at reducing the cost of disposables are in the pipeline for manufacturing. Company has GMP, and ISO13485, ISO9001, CE0120 certifications through SGS (UK) since 2007 authorizing free sale in EU while FDA (USA) approval is planned. In recent Global Market Reports (2014-20) published by four US market intelligence companies RenaconPharma has been rated among top 10-20 companies producing Hemodialysis Concentrates. Renacon is also recently offering Hemodialysis centres on turn-key basis to poor African countries. Company website tops in Google/MSN/Yahoo when searched by products and is in English, Russian, French & Spanish: www.renaconpharma.com

RenaconPharma is endeavoring to replace expensive imports with the affordable local solutions while exporting hemodialysis solutions to multiple countries from Philippines to Africa to as far as Jamaica due its best Quality-to-Cost ratio in the world better than India & China. While local sales to big institutions and 70% of market and exports are increasing and newer products need to be launched RenaconPharma has acquired 15 acres of land at FIEDMC for 5-times bigger production capacity while adding other sections like tablets, capsules, injectable, etc. taking advantage of its established brand name, goodwill coupled with strong R&D to launch new products.

Special disposable plastic "Blood tubing lines" (BTL) sets for dialysis (about 2.4 million sets/year, average Rs.180/- per set) are 100% imported in Pakistan. RenaconPharma has finalized the technology to produce the same in Pakistan exclusively hence a new plant has been planned at FIEDMC aiming to replace imports in the best interest of Country and the dialysis patients.

The new projects in FIEDMC will include plant for first-ever Government -approved pharma-grade salt (Sodium Chloride 50 tons/day initially about Rs.45/kg.) to be produced from purification of cheap rock salt in Pakistan, an opportunity unthought-of previously. The technology has been finalized at significantly lesser cost by Renacon team through R&D over a matter of years. It will be used in the dialysis solution industry (as 50%raw material) apart from supply to local Industry for drips and mostly to be exported. India imports raw salt from Pakistan and sells Pharma-grade to its industry and also exports. Several other grades of this salt and other compounds will also be produced through smaller additions in the same plant over a matter of time.

Treet Corporation Limited has acquired majority equity stake of the Company in January, 2017, in order to expand rapidly into endless possibilities and opportunities as envisaged by the Company (and by the Holding Company). Renacon's vision is to achieve one of the biggest manufacturer and global supplier of Dialysis disposables over the next decade eyeing the multinational giants through continuous growth and innovation through R&D.



the author

Top
Close
Close